Iobitridol

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 341423

CAS#: 136949-58-1

Description: Iobitridol is a biovhemical.

Chemical Structure

img
Iobitridol
CAS# 136949-58-1
Instruction

Theoretical Analysis

MedKoo Cat#: 341423
Name: Iobitridol
CAS#: 136949-58-1
Chemical Formula: C20H28I3N3O9
Exact Mass: 834.90
Molecular Weight: 835.169
Elemental Analysis: C, 28.76; H, 3.38; I, 45.59; N, 5.03; O, 17.24

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Iobitridol; Xenetix.

IUPAC/Chemical Name: 1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-((5-hydroxy-2-(hydroxymethyl)-1-oxopropyl)amino)-2,4,6-triiodo-N,N'-dimethyl-

InChi Key: YLPBXIKWXNRACS-PHIMTYICSA-N

InChi Code: InChI=1S/C20H28I3N3O9/c1-25(3-10(31)7-29)19(34)12-14(21)13(20(35)26(2)4-11(32)8-30)16(23)17(15(12)22)24-18(33)9(5-27)6-28/h9-11,27-32H,3-8H2,1-2H3,(H,24,33)/t10-,11+

SMILES Code: Ic1c(C(=O)N(C)C[C@@H](O)CO)c(I)c(C(N(C[C@@H](CO)O)C)=O)c(c1NC(C(CO)CO)=O)I

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 835.17 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Kim YS, Yoon SH, Choi YH, Park CM, Lee W, Goo JM. Nausea and vomiting after exposure to non-ionic contrast media: incidence and risk factors focusing on preparatory fasting. Br J Radiol. 2018 Apr 25:20180107. doi: 10.1259/bjr.20180107. [Epub ahead of print] PubMed PMID: 29694239.

2: Liu Y, Ji X, Liu J, Tong WWL, Askhatova D, Shi J. Tantalum Sulfide Nanosheets as a Theranostic Nanoplatform for Computed Tomography Imaging-Guided Combinatorial Chemo-Photothermal Therapy. Adv Funct Mater. 2017 Oct 19;27(39). pii: 1703261. doi: 10.1002/adfm.201703261. Epub 2017 Aug 21. PubMed PMID: 29290753; PubMed Central PMCID: PMC5743210.

3: Piacentino F, Fontana F, Micieli C, Angeretti MG, Cardim LN, Coppola A, Molinelli V, Piffaretti G, Novario R, Fugazzola C. Nonenhanced MRI Planning for Endovascular Repair of Abdominal Aortic Aneurysms: Comparison With Contrast-Enhanced CT Angiography. Vasc Endovascular Surg. 2018 Jan;52(1):39-45. doi: 10.1177/1538574417740508. Epub 2017 Nov 21. PubMed PMID: 29162027.

4: Böning G, Kahn JF, Kaul D, Rotzinger R, Freyhardt P, Pavel M, Streitparth F. CT follow-up in patients with neuroendocrine tumors (NETs): combined radiation and contrast dose reduction. Acta Radiol. 2018 May;59(5):517-526. doi: 10.1177/0284185117726101. Epub 2017 Aug 8. PubMed PMID: 28786299.

5: Benz MR, Szucs-Farkas Z, Froehlich JM, Stadelmann G, Bongartz G, Bouwman L, Schindera ST. Scan time adapted contrast agent injection protocols with low volume for low-tube voltage CT angiography: An in vitro study. Eur J Radiol. 2017 Aug;93:65-69. doi: 10.1016/j.ejrad.2017.05.017. Epub 2017 May 17. PubMed PMID: 28668433.

6: Park HJ, Park JW, Yang MS, Kim MY, Kim SH, Jang GC, Nam YH, Kim GW, Kim S, Park HK, Jung JW, Park JS, Kang HR. Re-exposure to low osmolar iodinated contrast media in patients with prior moderate-to-severe hypersensitivity reactions: A multicentre retrospective cohort study. Eur Radiol. 2017 Jul;27(7):2886-2893. doi: 10.1007/s00330-016-4682-y. Epub 2016 Dec 14. PubMed PMID: 27975150.

7: Kim SR, Lee JH, Park KH, Park HJ, Park JW. Varied incidence of immediate adverse reactions to low-osmolar non-ionic iodide radiocontrast media used in computed tomography. Clin Exp Allergy. 2017 Jan;47(1):106-112. doi: 10.1111/cea.12803. Epub 2016 Oct 12. PubMed PMID: 27648932.

8: Achenbach S, Paul JF, Laurent F, Becker HC, Rengo M, Caudron J, Leschka S, Vignaux O, Knobloch G, Benea G, Schlosser T, Andreu J, Cabeza B, Jacquier A, Souto M, Revel D, Qanadli SD, Cademartiri F; X-ACT Study Group. Erratum to: Comparative assessment of image quality for coronary CT angiography with iobitridol and two contrast agents with higher iodine concentrations: iopromide and iomeprol. A multicentre randomized double-blind trial. Eur Radiol. 2017 Feb;27(2):831. doi: 10.1007/s00330-016-4557-2. PubMed PMID: 27631105.

9: Tachibana A, Dias BO, Failla BB, Dos Santos Silva C, Belczak SQ, Mendes CA, Fioranelli A, Wolosker N. Optimized Protocol for Fast CT Angiography of Lower Limbs Using 160-Row Detector. J Comput Assist Tomogr. 2016 Nov/Dec;40(6):953-957. PubMed PMID: 27560013.

10: Achenbach S, Paul JF, Laurent F, Becker HC, Rengo M, Caudron J, Leschka S, Vignaux O, Knobloch G, Benea G, Schlosser T, Andreu J, Cabeza B, Jacquier A, Souto M, Revel D, Qanadli SD, Cademartiri F; X-ACT Study Group. Comparative assessment of image quality for coronary CT angiography with iobitridol and two contrast agents with higher iodine concentrations: iopromide and iomeprol. A multicentre randomized double-blind trial. Eur Radiol. 2017 Feb;27(2):821-830. doi: 10.1007/s00330-016-4437-9. Epub 2016 Jun 7. Erratum in: Eur Radiol. 2017 Feb;27(2):831. PubMed PMID: 27271922; PubMed Central PMCID: PMC5209424.

11: Wang GY, Xu CC, Wu KR, Liu GL, Zhang J, Pan YN, Tang YF. [Application value of Toshiba 320-row dynamic volumetric CT angiography in the diagnosis of venous erectile dysfunction]. Zhonghua Nan Ke Xue. 2016 Jul;22(7):635-640. Chinese. PubMed PMID: 28965383.

12: Klepiszewski K, Venditti S, Koehler C. Tracer tests and uncertainty propagation to design monitoring setups in view of pharmaceutical mass flow analyses in sewer systems. Water Res. 2016 Jul 1;98:319-25. doi: 10.1016/j.watres.2016.04.008. Epub 2016 Apr 13. PubMed PMID: 27110888.

13: Choi SY, Sung DJ, Yang KS, Kim KA, Yeom SK, Sim KC, Han NY, Park BJ, Kim MJ, Cho SB, Lee JH. Small (<4 cm) clear cell renal cell carcinoma: correlation between CT findings and histologic grade. Abdom Radiol (NY). 2016 Jun;41(6):1160-9. doi: 10.1007/s00261-016-0732-9. PubMed PMID: 27040407.

14: Tziatzios G, Gkolfakis P, Papanikolaou IS, Dimitriadis G, Triantafyllou K. An unusual case of prolonged post-endoscopic retrograde cholangiopancreatography jaundice. Hepatobiliary Pancreat Dis Int. 2016 Apr;15(2):220-2. PubMed PMID: 27020640.

15: Hinrichs JB, von Falck C, Hoeper MM, Olsson KM, Wacker FK, Meyer BC, Renne J. Pulmonary Artery Imaging in Patients with Chronic Thromboembolic Pulmonary Hypertension: Comparison of Cone-Beam CT and 64-Row Multidetector CT. J Vasc Interv Radiol. 2016 Mar;27(3):361-8.e2. doi: 10.1016/j.jvir.2015.11.046. Epub 2016 Jan 21. PubMed PMID: 26803575.

16: Chen J, Yang XQ, Qin MY, Zhang XS, Xuan Y, Zhao YD. Hybrid nanoprobes of bismuth sulfide nanoparticles and CdSe/ZnS quantum dots for mouse computed tomography/fluorescence dual mode imaging. J Nanobiotechnology. 2015 Oct 29;13:76. doi: 10.1186/s12951-015-0138-9. PubMed PMID: 26510511; PubMed Central PMCID: PMC4625725.

17: Wang H, Xiao X, Zhang W, Ma Z, Zhang JL, Tang L, Yang X. Imaging of acute superior mesenteric artery embolus using spectral CT in a canine model. Br J Radiol. 2015 Sep;88(1053):20150296. doi: 10.1259/bjr.20150296. Epub 2015 Jul 17. PubMed PMID: 26185922; PubMed Central PMCID: PMC4743579.

18: Manniesing R, Oei MT, van Ginneken B, Prokop M. Quantitative Dose Dependency Analysis of Whole-Brain CT Perfusion Imaging. Radiology. 2016 Jan;278(1):190-7. doi: 10.1148/radiol.2015142230. Epub 2015 Jun 25. PubMed PMID: 26114226.

19: Sidikou O, Simon N, Sergent G, Vasseur M, Pinturaud M, Richeval C, Allorge D, Décaudin B, Odou P. In Vitro Assessment of a New Extension Set Intended to Reduce Occupational Exposure to Antineoplastic Drugs During Hepatic Chemoembolisation. Cardiovasc Intervent Radiol. 2016 Jan;39(1):141-3. doi: 10.1007/s00270-015-1140-1. Epub 2015 Jun 3. PubMed PMID: 26037092.

20: Lewin M, Gelu-Simeon M, Ostos M, Boufassa F, Sobesky R, Teicher E, Meyer L, Fontaine H, Salmon-Céron D, Samuel D, Seror O, Trinchet JC, Duclos-Vallée JC. Imaging Features and Prognosis of Hepatocellular Carcinoma in Patients with Cirrhosis Who Are Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus. Radiology. 2015 Nov;277(2):443-53. doi: 10.1148/radiol.2015141500. Epub 2015 May 6. PubMed PMID: 25961631.